Chemokine receptor 9 (CCR9) polymorphisms: Susceptibility genes for inflammatory small bowel disease?

被引：0
|
作者：
McGovern, DP
Van Heel, D
Dechairo, B
Ahmad, T
Lench, N
Anderson, R
Jewell, D
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
M1442
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [41] Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation
    Schmutz, Caroline
    Cartwright, Alison
    Williams, Helen
    Haworth, Oliver
    Williams, John H. H.
    Filer, Andrew
    Salmon, Mike
    Buckley, Christopher D.
    Middleton, Jim
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (04)
  • [42] Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease
    Senhaji, Nezha
    Nadifi, Sellama
    Zaid, Younes
    Serrano, Aurora
    Rodriguez, Daniel Arturo Leon
    Serbati, Nadia
    Karkouri, Mehdi
    Badre, Wafaa
    Martin, Javier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (47) : 8300 - 8307
  • [43] Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease
    Nezha Senhaji
    Sellama Nadifi
    Younes Zaid
    Aurora Serrano
    Daniel Arturo Leon Rodriguez
    Nadia Serbati
    Mehdi Karkouri
    Wafaa Badre
    Javier Martín
    World Journal of Gastroenterology, 2017, 23 (47) : 8300 - 8307
  • [44] CCX282-B: First in class oral CCR9 antagonist for the treatment of inflammatory disorders of the bowel
    Jaen, Juan
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (07) : 711 - 712
  • [45] CCR9:CCL25 in melanoma metastatic to small intestine
    Kim A. Margolin
    Current Oncology Reports, 2009, 11 : 331 - 332
  • [46] CCR9:CCL25 in Melanoma Metastatic to Small Intestine
    Margolin, Kim A.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (05) : 331 - 332
  • [47] Chemokine receptor CCR9 suppresses the differentiation of CD4+CD8αα+ intraepithelial T cells in the gut
    Li, Can
    Kim, Hye Kyung
    Prakhar, Praveen
    Luo, Shunqun
    Crossman, Assiatu
    Ligons, Davinna L.
    Luckey, Megan A.
    Awasthi, Parirokh
    Gress, Ronald E.
    Park, Jung-Hyun
    MUCOSAL IMMUNOLOGY, 2022, 15 (05) : 882 - 895
  • [48] Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohn's disease
    Bekker, P.
    Velde, A.
    Pronk, I
    Keshav, S.
    Hommes, D.
    Hanauer, S.
    Ungashe, S.
    Zheng, W.
    Wright, K.
    Schall, T.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 647 - 647
  • [49] The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system
    Papadakis, KA
    Prehn, J
    Nelson, V
    Cheng, L
    Binder, SW
    Ponath, PD
    Andrew, DP
    Targan, SR
    JOURNAL OF IMMUNOLOGY, 2000, 165 (09): : 5069 - 5076
  • [50] MYO9B polymorphisms in patients with inflammatory bowel disease
    Nunez, C.
    Oliver, J.
    Mendoza, J. L.
    Gomez-Garcia, M.
    Pinero, A.
    Taxonera, C.
    Diaz-Rubio, M.
    Lopez-Nevot, M. A.
    de la Concha, E. G.
    Nieto, A.
    Urcelay, E.
    Martinez, A.
    Martin, J.
    GUT, 2007, 56 (09) : 1321 - 1322
12345